Ischemic Stroke: all 2,653 studies
Page 27 of 27. Open to participants first (936), then studies with results posted, then the rest; newest registration first within each.
- Microbubble-Enhanced Clotbust Treatment of Acute Ischemic StrokeTerminatedNCT00507806Phase 1/2
- Transcranial Ultrasound in Clinical SONothrombolysisTerminatedNCT00504842Phase 1/2
- Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a StrokeTerminatedNCT00499902Phase 2
- Fabry : National Initiative of ScreeningCompletedNCT00484549Not applicable
- Prognostic Value of Cardiac and Renal Markers in Ischemic Stroke and Transient Ischemic AttackCompletedNCT00479518
- Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic StrokeCompletedNCT00478478
- Study of Autologous Stem Cell Transplantation for Patients With Ischemic StrokeCompletedNCT00473057Phase 1
- Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic StrokeCompletedNCT00472381Phase 2/3
- Sildenafil (Viagra) Treatment of Subacute Ischemic StrokeTerminatedNCT00452582Phase 1
- Prognostic Significance of the Baroreflex Sensitivity Changes After Acute Ischemic StrokeStatus unknownNCT00422474
- Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)CompletedNCT00419705Phase 3
- Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.CompletedNCT00418275Phase 1/2
- Study of Aspirin and TPA in Acute Ischemic StrokeWithdrawnNCT00417898Phase 1
- The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)TerminatedNCT00401310Phase 2
- Continuous Positive Airway Pressure for the Treatment of StrokeCompletedNCT00368628Phase 2
- hsCRP in Japan Statin Treatment Against Recurrent Stroke (J-STARS hsCRP)CompletedNCT00361699Phase 3
- Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)CompletedNCT00361530Phase 3
- AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese MedicineCompletedNCT00351806Phase 4
- Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of SymptomsCompletedNCT00343174Phase 3
- PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO)SuspendedNCT00335296Not applicable
- Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TESTTerminatedNCT00331721Phase 2
- Quality Improvement in Stroke Prevention (QUISP)CompletedNCT00328640Phase 4
- Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With HypertensionCompletedNCT00325637Phase 3
- Multi MERCI (Mechanical Embolus Removal in Cerebral Ischemia [MERCI™])CompletedNCT00318071Not applicable
- Study of Early Versus Delayed Carotid Endarterectomy (CEA) for Small to Medium-sized Ischemic Stroke Caused by High-grade Carotid StenosisWithdrawnNCT00315562Phase 1
- Myocardial Damage In Patients With Cerebral InfarctionCompletedNCT00306579
- ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic StrokeTerminatedNCT00300196Phase 3
- Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic StrokeCompletedNCT00283088Phase 1
- Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)TerminatedNCT00272909Phase 2
- Cilostazol in Acute Ischemic Stroke Treatment (CAIST)CompletedNCT00272454Phase 4
- Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial DissectionWithdrawnNCT00265408Phase 1
- Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) TrialCompletedNCT00250991Phase 1/2
- Cerebral Artery Stenosis, Coronary Artery Disease and ArrhythmiaStatus unknownNCT00247533Phase 4
- Study of ONO-2506 in Patients With Acute Ischemic StrokeCompletedNCT00229177Phase 2/3
- Induced Hypertension for Acute Ischemic StrokeCompletedNCT00227448Phase 2
- Microbubbles and Ultrasound in Stroke Trial: MUST StudyTerminatedNCT00222040Phase 2
- Concentric Retriever Device (CRD) in Acute Ischemic StrokeCompletedNCT00203710Not applicable
- The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression IllnessCompletedNCT00196040Not applicable
- Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical EmbolismStatus unknownNCT00196027Not applicable
- Abciximab in Wake-up StrokeTerminatedNCT00167765Phase 3
- Continuous Positive Airway Pressure Ventilation After Acute Ischemic StrokeCompletedNCT00151177Phase 1/2
- Safety and Efficacy Study in Acute Ischaemic StrokeCompletedNCT00144014Phase 2
- Ancrod (Viprinex™) for the Treatment of Acute, Ischemic StrokeTerminatedNCT00141011Phase 3
- FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic StrokeTerminatedNCT00132509Phase 2
- Treatment With AX200 for Acute Ischemic StrokeCompletedNCT00132470Phase 2
- Intravenous Administration of Microplasmin for Treatment of Acute Ischemic StrokeCompletedNCT00123305Phase 2
- Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)CompletedNCT00119717Phase 3
- Siblings With Ischemic Stroke StudyCompletedNCT00108940
- PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)CompletedNCT00077805Phase 4
- A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)TerminatedNCT00073372Phase 3
- A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic StrokeTerminatedNCT00046761Phase 2/3
- Repinotan in Patients With Acute Ischemic StrokeCompletedNCT00044915Phase 2
- A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)CompletedNCT00044057Phase 2